萬科企業(02202.HK)延長2022年公司債券(第二期)簿記建檔時間
格隆匯6月1日丨萬科企業(02202.HK)公吿,萬科企業股份有限公司(以下簡稱“發行人”或“公司”)向專業投資者公開發行面值不超過80億元的公司債券已獲得中國證券監督管理委員會“證監許可[2021]970號”文同意註冊。
根據《萬科企業股份有限公司2022年面向專業投資者公開發行公司債券(第二期)發行公吿》,發行人及簿記管理人將於2022年6月1日14:00至19:00以簿記建檔的方式向網下投資者進行利率詢價,並根據簿記建檔結果在預設的利率區間內確定本期債券的最終票面利率。
因簿記建檔當日部分投資者履行程序的原因,經發行人、簿記管理人及全體投資人協商一致,將簿記建檔結束時間由2022年6月1日19:00延長至2022年6月1日21:00。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.